Stephanie Lee, MD, MPH
Professor and Associate Director
Clinical Research Division, Fred Hutch
David and Patricia Giuliani/Oliver Press Endowed Chair in Cancer Research
Fred Hutch
Dr. Stephanie Lee is a hematologist and blood and marrow transplant physician-scientist who treats patients with leukemia, lymphoma and other blood and bone marrow diseases. Her research aims to improve the lives of bone marrow and blood stem cell transplant recipients. She leads a nationwide research network that focuses on improving the understanding of chronic graft-vs.-host disease, or GVHD, and the best ways to prevent, diagnose and treat it. In this common, long-term and sometimes life-threatening transplant complication, donor immune cells attack the recipient’s body. Dr. Lee is especially interested in the chronic form of GVHD, which causes symptoms ranging from painful dry eye and mouth to skin thickening, lung problems and susceptibility to infections. She also studies many other transplant-related topics, including survivorship and patient-reported outcomes. She serves as research director of Fred Hutch’s Long-Term Follow-Up Program, which tracks the outcomes of more than 5,000 transplant survivors.
Other Appointments & Affiliations
Affiliate Investigator, Translational Science and Therapeutics Division, Fred HutchAffiliate Investigator
Translational Science and Therapeutics Division, Fred Hutch
Professor
University of Washington
Past President
American Society of Hematology
Education
MPH, Harvard School of Public Health, 1996
MD, Stanford University of Medicine, 1990
BS, University of Washington, 1984
Research Interests
Survivorship issues, quality-of-life and the impact of chronic graft-versus-host-disease
"Some of the advances [in hematology research], such as genetically engineered T cells, sound like science fiction, except that the technology is successfully treating blood cancers that previously didn’t respond to other therapies."
— Dr. Stephanie Lee